Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2022Journal of Experimental & Clinical Cancer ResearchOpen Access

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDiego de Miguel‐PérezMount Sinai Health SystemARAlessandro RussoVita-Salute San Raffaele UniversityÓAÓscar ArrietaInstituto Nacional de Cancerología

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Miguel‐Pérez et al. (2022) studied this question.

synapsesocial.com/papers/6a7a059e8a3ae1c742328b7bhttps://doi.org/10.1186/s13046-022-02379-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Textural Features for Image Classification1973 · 22,933 citations
  2. 2A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC2020 · 38 citations
  3. 3PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC2018 · 256 citations
  4. 4Novel Biomarkers of Dynamic Blood PD-L1 Expression for Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients2021 · 77 citations